OPTIMI HEALTH CORP. (8BN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, OPTIMI HEALTH CORP. (8BN) has a cash flow conversion efficiency ratio of -0.094x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-333.32K ≈ $-389.69K USD) by net assets (€3.54 Million ≈ $4.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see OPTIMI HEALTH CORP. stock valuation for the company's overall valuation and market capitalisation.
OPTIMI HEALTH CORP. - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how OPTIMI HEALTH CORP.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
OPTIMI HEALTH CORP. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of OPTIMI HEALTH CORP. ranked by their cash flow conversion efficiency. See debt repayment capacity of OPTIMI HEALTH CORP. to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Thiensurat Public Company Limited
BK:TSR
|
0.031x |
|
Van Elle Holdings PLC
LSE:VANL
|
0.114x |
|
Manitex Capital Inc
V:MNX
|
0.000x |
|
ENvue Medical Inc.
NASDAQ:FEED
|
-0.087x |
|
East Star Resources PLC
LSE:EST
|
-0.884x |
|
Contagious Gaming Inc
V:CNS
|
0.004x |
|
Ondine Biomedical Inc
LSE:OBI
|
-3.853x |
|
Bitcoin Fund Unit
TO:QBTC
|
-0.019x |
Annual Cash Flow Conversion Efficiency for OPTIMI HEALTH CORP. (2022–2025)
The table below shows the annual cash flow conversion efficiency of OPTIMI HEALTH CORP. from 2022 to 2025. View OPTIMI HEALTH CORP. (8BN) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | €6.57 Million ≈ $7.68 Million |
€-2.63 Million ≈ $-3.07 Million |
-0.400x | +10.56% |
| 2024-09-30 | €9.58 Million ≈ $11.20 Million |
€-4.28 Million ≈ $-5.01 Million |
-0.447x | -64.02% |
| 2023-09-30 | €13.21 Million ≈ $15.44 Million |
€-3.60 Million ≈ $-4.21 Million |
-0.273x | +4.63% |
| 2022-09-30 | €16.02 Million ≈ $18.73 Million |
€-4.58 Million ≈ $-5.35 Million |
-0.286x | -- |
About OPTIMI HEALTH CORP.
Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and… Read more